| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |